Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, Northern Italy

Emerging Infectious Diseases

Volumn 15, Issue 2, 2009, Pages 250-257

  Tinelli, Marco ^a   Monaco, Monica ^b   Vimercati, Maurizio ^a   Ceraminiello, Antonio ^a   Pantosti, Annalisa ^b  

^a Hospital of Lodi   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; METICILLIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CHILD; DRAIN; FEMALE; FURUNCULOSIS; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; ITALY; MALE; MASTITIS; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOTHER; NEWBORN; NOSE SMEAR; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PUSTULE; RELAPSE; SCHOOL CHILD; SCREENING; SKIN ABSCESS; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; SUBURBAN AREA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; EXOTOXINS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; LEUKOCIDINS; MALE; MASTITIS; METHICILLIN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POSTPARTUM PERIOD; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 64249156964     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1502.080010     Document Type: Article

References (40)

1. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144:309-17.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-74. DOI: 10.1056/NEJMoa055356
3. Bartels MD, Boye K, Larsen A, Skov R, Westh H. Rapid increase of genetically-diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerg Infect Dis. 2007;13:1533-40.
4. Del Giudice P, Blanc V, Durupt F, Bes M, Martinez JP, Counillon E, et al. Emergence of two populations of methicillin-resistant Staphy- lococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol. 2006;154:118-24. DOI: 10.1111/J.1365- 2133.2005.06910.x
5. Tristan A, Bes M, Meugnier M, Lina G, Bozdogan B, Courvalin P, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin- resistant Staphylococcus aureus. Emerg Infect Dis. 2007;13:594-600.
6. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resis- tant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest. 2007;87:3-9. DOI: 10.1038/labinvest.3700501
7. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32. DOI: 10.1086/313461
8. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis. 2003;37:1050-8. DOI: 10.1086/378277
9. Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N, Bhar- adwa K, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis. 2007;44:471-82. DOI: 10.1086/511033
10. Kearns AM, Ganner M, Holmes A. The 'Oxford Staphylococcus': a note of caution. J Antimicrob Chemother. 2006;58:480-1. DOI: 10.1093/jac/dkl230
11. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet. 2005;365:1256-8. DOI: 10.1016/S0140-6736(05)74814-5
12. Boubaker K, Diebold P, Blanc DS, Vandenesch F, Praz G, Dupuis G, et al. Panton-Valentine leukocidin and staphyloccoccal skin infections in schoolchildren. Emerg Infect Dis. 2004;10:121-4.
13. Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A, et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis. 2007;44:e88-95. DOI: 10.1086/517503
14. Lesens O, Haus-Cheymol R, Dubrous P, Verret C, Spiegel A, Bonnet R, et al. Methicillin-susceptible, doxycycline-resistant Staphylococ- cus aureus, Cote d'Ivoire. Emerg Infect Dis. 2007;13:488-90.
15. Strauss R, Amsler K, Jacobs M, Bush K, Noel G. Regional variation in Panton-Valentine leukocidin positivity among S. aureus isolates in complicated skin and skin structure infections. In: 17th European Congress of Clinical Microbiology and Infectious Diseases. Munich, Germany; 2007 March 31-April 3; Abstract 1321. Clin Microb Infect. 2007;29(S2).
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Vol. 26, No. 1; Wayne (PA): The Institute; 2006.
17. Monaco M, Antonucci R, Palange P, Venditti M, Pantosti A. Me- thicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis. 2005;11:1647-8.
18. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999;37:3556-63.
19. Chung M, de Lencastre H, Matthews P, Tomasz A, Adamsson I, Aires de Sousa M, et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist. 2000;6:189-98.
20. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
21. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilo-cus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Mi- crobiol. 2000;38:1008-15.
22. Tinelli M, Pantosti A, Lusardi C, Vimercati M, Monaco M. First detected case of community-acquired methicillin-resistant Staphy- lococcus aureus skin and soft tissue infection in Italy. Euro Surveill. 2007;12:E070412.1. Available from http://www.eurosurveillance.org/ew/2007/.asp#1.
23. Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23:123-7. DOI: 10.1097/01.inf.0000109288.06912.21
24. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24:362-86. DOI: 10.1086/502213
25. Ho PL, Cheung C, Mak GC, Tse CW, Ng TK, Cheung CH, et al. Molecular epidemiology and household transmission of community-associated methicillin-resistant Staphylococcus aureus in Hong Kong. Diagn Microbiol Infect Dis. 2007;57:145-51. DOI: 10.1016/j.diagmicrobio.2006.08.003
26. Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, Heck ME, Pluister GN, Eijkelkamp BA, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006;44:2994-6. DOI: 10.1128/ JCM.00846-06
27. Urth T, Juul G, Skov R, Schonheyder HC. Spread of a methicillin- resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol. 2005;26:144-9. DOI: 10.1086/502518
28. Sax H, Posfay-Barbe K, Harbarth S, Francois P, Touveneau S, Pes- soa-Silva CL, et al. Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect. 2006;63:93-100. DOI: 10.1016/j.jhin.2005.11.016
29. Fortunov RM, Hulten KG, Hammerman WA, Mason EO Jr, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006;118:874-81. DOI: 10.1542/peds.2006-0884
30. Farr BM. Mupirocin to prevent Staphylococcus aureus infections. N Engl J Med. 2002;346:1905-6. DOI: 10.1056/NEJMed020048
31. Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother. 2001;48:143-4. DOI: 10.1093/jac/48.1.143
32. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin- resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-20. DOI: 10.1128/JCM.41.11. 5113-5120.2003
33. Gosbell IB, Barbagiannakos T, Neville SA, Mercer JL, Vickery AM, O'Brien FG, et al. Non-multiresistant methicillin-resistant Staphylococcus aureus bacteraemia in Sydney, Australia: emergence of EMR- SA-15, Oceania, Queensland and Western Australian MRSA strains. Pathology. 2006;38:239-44. DOI: 10.1080/00313020600699227
34. Amorim ML, Faria NA, Oliveira DC, Vasconcelos C, Cabeda JC, Mendes AC, et al. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J Clin Microbiol. 2007;45:2881-8. DOI: 10.1128/JCM.00603-07
35. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococ- cus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99:7687-92. DOI: 10.1073/pnas.122108599
36. Linde H, Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U, et al. Healthcare-associated outbreaks and community- acquired infections due to MRSA carrying the Panton-Valentine leu- cocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis. 2005;24:419-22. DOI: 10.1007/s10096-005-1341-7
37. Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med. 2007;13:1405-6. DOI: 10.1038/nm1207-1405
38. Labandeira-Rey M, Couzon F, Boisset S, Brown E, Bes M, Benito Y, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315:1130-3. DOI: 10.1126/ science.1137165
39. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphy- lococcus aureus disease? J Infect Dis. 2006;194:1761-70. DOI: 10.1086/509506
40. Campbell SJ, Deshmukh HS, Nelson CL, Bae IG, Stryjewski ME, Federspiel JJ, et al. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol. 2008;46:678-84. DOI: 10.1128/JCM.01822-07